גאלבוס 50 מ"ג

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

VILDAGLIPTIN 50 MG

Tilgængelig fra:

NOVARTIS PHARMA SERVICES AG

ATC-kode:

A10BH02

Lægemiddelform:

TABLETS

Indgivelsesvej:

PER OS

Fremstillet af:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapeutisk gruppe:

VILDAGLIPTIN

Terapeutiske indikationer:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Autorisation dato:

2013-11-01